webinars

PAST WEBINARS

Fueling TPD Drug Discovery: In Vitro Evaluation and Synthesis Strategies

Target Protein Degradation (TPD) has merged as an innovative "event-driven" therapeutic approach, overcoming the limitations of traditional small molecule drugs by enabling the targeting of "undruggable" proteins with high potency and selectivity. It offers a significant advantage by targeting these proteins at low doses, thus bringing new hope for clinical treatment. Molecular glues and PROTACs have emerged as rapidly evolving molecules in the TPD field, however, their complex mechanisms introduce significant hurdles in pre-clinical drug discovery.
Watch Now
PAST WEBINARS

Exploring Peptide In-Vitro ADME Properties: From Natural Peptides to Synthetic Analogues

Join us Friday, June 13, 2025 | 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central) with interest in peptide drug development, formulation scientists, pharmacokinetic experts and anyone interested in advancing the stability and performance of peptide-based therapeutics.
Watch Now
PAST WEBINARS

From Hit to IND: Streamlining Drug Discovery Through Multidisciplinary Integration

Drug discovery is inherently a time-consuming and costly endeavor. How can today's new drug innovators accelerate their programs through a simple, fast, and streamlined process—especially when working with multiple vendors? Should they rely on a single partner for end-to-end support, or engage specialized vendors for different workstreams such as chemistry, biology, and DMPK?
Watch Now
PAST WEBINARS

Streamlining GLP-1 Drug Development from Synthesis to Testing

Fuelled by the global surge in type 2 diabetes and obesity, the GLP-1 market is set to explode from $20 billion in 2024 to $50 billion by 2030, offering vast opportunities f
Watch Now
PAST WEBINARS

Optimizing Formulation Strategies for Poorly Soluble Compounds: Insights into Bioavailability Enhancement and Accelerated Development

With 70% of small molecule drug candidates classified as poorly soluble (BCS Class II and IV), achieving adequate absorption in the gastrointestinal (GI) tract remains a critical challenge in drug dev
Watch Now
PAST WEBINARS

Transforming Oral Drug Products for Late-Phase and Commercial Excellence

Join our exclusive webinar to discover cutting-edge technologies for extending product life cycles through innovative reformulation strategies….
Watch Now
Total 18 123
✉️Contact Us
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all